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GUIDE FOR AUTHORS
Value in Health is a peer-reviewed publication of the International Society for
Pharmacoeconomics and Outcomes Research. Its mission is to provide a
forum for the advancement and dissemination of knowledge and research in
pharmacoeconomics and the health-related outcomes of disease and treat-
ment processes. The journal therefore solicits original contributions in ap-
plied and theoretical pharmacoeconomics, and in the theory, measurement,
and analysis of the health-related outcomes relevant to forwarding scholarly
and public dialogue about the assessment of value in health and health care.
In keeping with its broad mission, Value in Health will also accept method-
ology papers and critical reviews of empirical and theoretical literature in
pharmacoeconomics and outcomes research.
Value in Health does not consider papers reporting data series or data
sets that do not include appropriate statistical confidence intervals
and/or other measures of statistical imprecision. Value in Health also
does not consider papers reporting modeling results that do not include
sensitivity analysis of key and influential model parameters.
Authors for whom English is a second language may choose to have
their manuscript professionally edited before submission or during the
review process. Authors wishing to pursue a professional English-lan-
guage editing service should make contact and arrange payment with
the editing service of their choice. For more details regarding the rec-
ommended services, please refer to http://support.elsevier.com/.
For more details about the types of articles that are suitable for Value
in Health, see: http://www.ispor.org/publications/value/submit.asp.
I. ETHICS IN PUBLISHING
For information on Ethics in Publishing and Ethical guidelines for journal
publication see http://www.elsevier.com/publishingethics and http://
www.elsevier.com/ethicalguidelines.
II. CONFLICT OF INTEREST
All authors must disclose any financial and personal relationships with
other people or organisations that could inappropriately influence (bias)
their work. Examples of potential conflicts of interest include employ-
ment, consultancies, stock ownership, honoraria, paid expert testimony,
patent applications/registrations, and grants or other funding. See also
http://www.elsevier.com/conflictsofinterest.
III. SUBMISSION DECLARATION
Submission of an article implies that the work described has not been
published previously (except in the form of an abstract or as part of
a published lecture or academic thesis), that it is not under consid-
eration for publication elsewhere, that its publication is approved by
all authors and tacitly or explicitly by the responsible authorities
where the work was carried out, and that, if accepted, it will not be
published elsewhere including electronically in the same form, in
English or in any other language, without the written consent of the
copyright-holder.
IV. RETAINED AUTHOR RIGHTS
As an author you (or your employer or institution) retain certain rights; for
details you are referred to: http://www.elsevier.com/authorsrights.
V. FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow
authors whose articles appear in journals published by Elsevier, to
comply with potential manuscript archiving requirements as specified as
conditions of their grant awards. To learn more about existing agree-
ments and policies please visit http://www.elsevier.com/fundingbodies.
VI. MANUSCRIPT SUBMISSION AND SPECIFICATIONS
To submit a manuscript to Value in Health, please go to: http://mc.
manuscriptcentral.com/vih. For assistance, authors may contact the
Value in Health editorial office at: viheditor@ispor.org.
If submissions are larger than 500 KB, they should be compressed
using PKZIP or WINZIP.
Authors will be required to assign copyright of their papers. Copyright
assignment is a condition of publication and papers will not be passed to
the publisher for production unless copyright has been assigned. An
appropriate copyright assignment form can be found at the following
address: http://www.ispor.org/publications/value/Value-In-Health-Copyright-
Transfer-Form_2011.pdf. A faxed copy of this completed and signed form
is acceptable; fax to 609-586-4982 or email to: viheditor@ispor.org.
If excerpts from other copyrighted works are included, the author(s)
must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by authors
in these cases: please consult http://www.elsevier.com/permissions.
Each Submission should contain separate documents as follows:
i. COVER LETTER. The cover letter should include: 1) title of the man-
uscript; 2) name of the document file(s) containing the manuscript and the
software (and version) used; 3) name and all contact information for the
corresponding author and a statement as to whether the data, models, or
methodology used in the research are proprietary; 4) names of all spon-
sors of the research and a statement of all direct or indirect financial
relationships the authors have with the sponsors; and 5) if applicable, a
statement that the publication of study results was not contingent on the
sponsor’s approval or censorship of the manuscript.
ii. TITLE PAGE. The title page should contain the following: 1) title; 2) full
names (first and surname) of all authors including academic degrees and
affiliation(s); 3) name, mailing and email addresses, telephone and fax num-
bers of corresponding author (with whom all correspondence will take place
unless other arrangements are made); 4) all sources of financial or other
support for the manuscript (if no funding was received, this should be noted
on the title page); 5) at least four key words for indexing purposes; and 6) a
running title of not more than 45 characters including spaces.
iii. MANUSCRIPTS. Manuscripts must be written in English, typed in either
MicrosoftWord (Version 2003or later; .doc or .docx file format).Manuscripts
should be in 8.5x11-inch page format, double-spaced with 1-inch margins on
all sides and size 10 font (Arial or Times New Roman fonts are preferred).
Minimal formatting should be used, i.e., no justification, italics, bold, indenting,
etc. There should be no hard returns at the end of lines. Double-spacing after
each element is requested (e.g., headings, titles, paragraphs, legends).
There is no limit on manuscript length, but length in terms of clarity and
conciseness will be considered in the editorial process. The ‘Uniform Require-
ments for Manuscripts Submitted to Biomedical Journals’ should be con-
sulted for specific style issues not addressed here (www.acponline.org, Ann
Intern Med 1997;126:36-47).
a.ABSTRACT.An abstract of 250words or less is required, summarizing
the work reported in themanuscript. Original researchmanuscripts should
use a structured format for the abstract, i.e., Objectives, Methods, Re-
sults, and Conclusions.
b. TEXT. The body of the manuscript should be divided into sections that
facilitate reading and comprehension of the material. This should normally
include sections with the major headings: Introduction, Methods, Results,
Conclusions, Acknowledgments (if needed), and References. There should
be no footnotes. Figures (inclusive of figure legends) and Tables must be
submitted each as separate documents.
c. REFERENCES. References should be listed in a separate section and
numbered consecutively with Arabic numerals in the order in which they
are cited in the text. Citing unpublished or non-peer-reviewed work such as
abstracts and presented papers is discouraged. Personal communica-
tionsmay be indicated in the text as long as written acknowledgment from
the authors of the communications accompanies the manuscript. Refer-
ence style should follow that of Index Medicus. Spell out single-word
journals and abbreviate all others according to the style of Index Medicus.
If there are more than four authors, use only the names of the first three,
followed by et al.
The three most common types of references are illustrated below
for example.
Journal article: Surname and initials of author(s), title of article, name of
journal, year, volume number, first and last page.
Arocho R, McMillan CA. Discriminant and criterion evaluation of the
U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American
population with benign hyperplasia. Med Care 1998;36:766–72.
Book: Surname and initials of author(s)/editor(s), title and subtitle,
volume, edition (other than first), city, publisher, year.
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill,
1984.
Chapter in Book: Surname and initials of author(s), title of chapter,
author(s)/editor(s) of book, title of book, volume, edition (other than
first), city, publisher, year.
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-
effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., eds.,
Cost-effectiveness in Health and Medicine. New York: Oxford University
Press, 1996.
Website: Title of article on web. www.document. Available from:
http://www... [Accessed Month day, year].
International Society for Pharmacoeconomics and Outcomes Re-
search (ISPOR). ISPOR Good Outcomes Research Practices
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Index. Available from: http://www.ispor.org/workpaper/practices_
index.asp. [Accessed January 1, 2011].
iv. TABLES. Tables should be clearly labeled, neatly typed, and easy to
understand without reference to the text. Each should be double-
spaced and presented on a separate page. Statistical estimates
should indicate parameter estimates and, as appropriate, t ratios or
standard error, statistical significance, sample size, and other relevant
information. All abbreviations must be explained below each table.
Each table should be numbered and have a self-explanatory title.
v. FIGURES. Figures should each be submitted as a separate image
file, not embedded in the manuscript document or in a slide presen-
tation. Cite figures consecutively, as they appear in the text, with
Arabic numbers (Figure 1, Figure 2, Figure 3A, etc.). If, together with
your accepted article, you submit usable color figures then the Journal
will ensure, at no additional charge, that these figures will appear in
color on the Web (e.g., ScienceDirect and other sites) regardless of
whether or not these illustrations are reproduced in color in the printed
version. There will be a charge for color reproduction in print; you will
receive information regarding the costs from Elsevier after receipt of
your accepted article. Please indicate your preference for color in
print or on the Web only. Each figure must be assigned a brief title (as
few words as possible, and reserving abbreviations for the legend) as
well as a legend. The corresponding legend should be typed double-
spaced on a separate page. All symbols, arrows, and abbreviations
must be explained in the legend. Please submit files with a resolution
of at least 300 DPI. Line artwork should contain a resolution of least
1000 DPI. Elsevier recommends submitting figures in the following
formats: TIFF, JPG, EPS, and PDF. Please be sure to delete any
identifying patient information such as name, social security number,
etc. Photographs in which a person’s face is recognizable must be
accompanied by a letter of release from that person explicitly granting
permission for publication in the Journal. For any previously published
material, written permission for both print and electronic reprint rights
must be obtained from the copyright holder. For further explanation
and examples of artwork preparation, see Elsevier’s Author Artwork
Instructions at www.elsevier.com/artwork.
vi. SUPPLEMENTARY MATERIAL. You may submit appendixes that
describe either methods or results in more detail if these are needed
for clarity of understanding by either peer reviewers or readers. If
appropriate, materials suitable for Web publication but not print pub-
lication (eg, audio or video files, see below) can also be submitted. If
you do so, indicate the particular reasons for the appendix and
whether you are submitting it for possible Web publication or simply
for peer review purposes. Value in Health accepts audio and video files
as ancillaries to the main article. Audio files should be in .mp3 format;
the recommended upper limit for the size of a single file is 10 Mb.
Video files should be submitted in .mpg or .mp4 format; the recom-
mended upper limit for the size of a single file is 10 Mb. Any alternative
format supplied may be subject to conversion (if technically possible)
prior to online publication.
vii. SURVEY INSTRUMENT. For papers analyzing preferences, ViH
requires the submission of a copy of the survey instrument (translated
into English in case of different original language) used to generate the
preference data. This is to help in the review process and the survey
instrument need not appear in a final publication. If the authors wish
the questionnaire to be published with the paper, it should be submit-
ted through ScholarOne Manuscripts as part of the paper. If they do
not wish it to be published, it should be submitted through ScholarOne
Manuscripts as Supporting Information and then will be sent to the
reviewers as a reviewer’s appendix.
VII. DATA, MODELS, AND METHODOLOGY
All authors must agree to make their data available at the Editor’s
request for examination and re-analysis by referees or other persons
designated by the Editor. All models and methodologies must be pre-
sented in sufficient detail to be fully comprehensible to readers.
VIII. AUTHOR ANONYMITY
From September 15, 2003, it is the policy of Value in Health that peer
review of submitted manuscripts is double blinded, i.e., the reviewers do
not know the names of the authors of manuscripts and the authors do
not know the names of the reviewers. Blinded reviews are common
practice at many important scientific and medical journals.
IX. THE REVIEW PROCESS
All manuscripts deemed appropriate for Value in Health after initial screening
will be reviewed by at least two peer reviewers. The objective of the journal
is to complete peer review and reach editorial decision within ten to twelve
weeks of submission, at which time the corresponding author will receive
written notification, including anonymous reviewer commentary.
X. AUTHOR TRACKING SERVICES
Authors may track accepted articles at http://www.elsevier.com/
trackarticle and set up e-mail alerts to inform them when an article’s
status has changed. Contact details for questions arising after accep-
tance of an article, especially those relating to proofs, will be provided by
the publisher.
XI. PROOFS
Proofs will be sent electronically to the Authors to be carefully checked
for printer’s errors. Substantive changes or additions to the edited
manuscript cannot be allowed at this stage. Corrected proofs
should be returned to the publisher within 2 days of receipt.
XII. OFFPRINTS
The corresponding author, at no cost, will be provided with a PDF file of
the article via e-mail. For an extra charge, paper offprints can be ordered
via the offprint order form which is sent once the article is accepted for
publication. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer
outlining the terms and conditions of use.
